Home systolic blood pressure on the morning of dialysis days has prognostic impact for hypertensive hemodialysis patients

Clinical and Experimental Nephrology

Volumn 16, Issue 3, 2012, Pages 427-432

  Ogura, Makoto ^a   Yamada, Yukiko ^a   Terawaki, Hiroyuki ^a   Hamaguchi, Akihiko ^a   Kimura, Yasuo ^b   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shin Kashiwa Clinic   (Japan)

Author keywords

Cardiovascular events; Hemodialysis; Home blood pressure; Hypertension; Left ventricular hypertrophy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME SYSTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS;

EID: 84863723221     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0575-1     Document Type: Article

References (30)

1. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y, et al. Role of systolic BP in determining prognosis of hemodialyzed patients. Am J Kidney Dis. 1995;25:405-12.
2. Salem MM. Hypertension in the hemodialysis population: A survey of 649 patients. Am J Kidney Dis. 1995;26:461-8.
3. Mittal SK, Kowalski E, Trenkle J, McDonough B, Halinski D, Devlin K, et al. Prevalence of hypertension in a hemodialysis population. Clin Nephrol. 1999;51:77-82.
4. Grekas D, Bamichas G, Bacharaki D, Goutzaridis N, Kasimatis E, Tourkantonis A. Hypertension in chronic hemodialysis patients: Current view on pathophysiology and treatment. Clin Nephrol. 2000;53:164-8.
5. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK, HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol. 2001;21:280-8.
6. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291-7.
7. Agarwal R. Hypertension and survival in chronic hemodialysis patients-past lessons and future opportunities. Kidney Int. 2005;67:1-13.
8. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):1-153.
9. Agarwal R, Peixoto AJ, Santos SF, Zoccali C. Pre and post dialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1:389-98.
10. Agarwal R, Brim NJ, Mahenthiran J, Andersen MJ, Saha C. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Hypertension. 2006;47:62-8.
11. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55:762-8.
12. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
13. Harper J, Nicholas J, Webbc L, Casula A, Williams AJ. UK Renal Registry 12th Annual Report (December 2009). Chapter 11: blood pressure profile of prevalent patients receiving dialysis in the UK in 2008: National and centre specific analyses. Nephron Clin Pract. 2010;115:c239-60.
14. Davenport A, Cox C, Thuraisingham R. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008;73:759-64.
15. Agarwal R, Andersen MJ, Bishu K, Saha C. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Kidney Int. 2006;69:900-6.
16. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286-90.
17. Harnett JD, Kent GM, Barre PE, Taylor R, Parfrey PS. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol. 1994;4:1486-90.
18. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant. 1996;11:1277-85.
19. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, CREED Investigators, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001;12:2768-74.
20. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol. 2001;12:2759-67.
21. Moriya H, Ohtake T, Kobayashi S. Aortic stiffness, left ventricular hypertrophy and weekly averaged blood pressure (WAB) in patients on haemodialysis. Nephrol Dial Transplant. 2007;22:1198-204.
22. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485-91.
23. Tripepi G, Fagugli RM, Dattolo P, Parlongo G, Mallamaci F, Buoncristiani U, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int. 2005;68:1294-302.
24. Moriya H, Oka M, Maesato K, Mano T, Ikee R, Ohtake T, et al. Weekly averaged blood pressure is more important than a singlepoint blood pressure measurement in the risk stratification of dialysis patients. Clin J Am Soc Nephrol. 2008;3:416-22.
25. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561-9.
26. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, et al. Low diastolic blood pressure, hypoalbuminemia and risk of death in a cohort of chronic hemodialysis patients. Kidney Int. 1997;51:1212-7.
27. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507-17.
28. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793-808.
29. Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, et al. Prescription of antihypertensive agents to haemodialysis patients: Time trends and associations with patient characteristics, country and survival in the DOPPS. Nephrol Dial Transplant. 2009;24:2809-16.
30. Metoki H, Ohkubo T, Imai Y. Diurnal blood pressure variation and cardiovascular prognosis in a community-based study of Ohasama, Japan; diurnal variations in blood pressure: Clinical implications and pathogenesis. Hypertens Res. 2010;33:652-6.